ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Alteration of saliva and blood ghrelin, obestatin, leptin and weight based on adjuvant chemotherapy treatment in early-stage operated breast cancer patients

Nimet Yilmaz, Aziz Karaoglu, Kader Ugur, Meltem Yardim, Suleyman Aydin.



Abstract
Download PDF Cited by 0 ArticlesPost

Aim: To evaluate the weight change and ghrelin, obestatin and leptin levels in operated early stage breast cancer patients receiving adjuvant chemotherapy.
Material and Methods: This study was conducted with 22 operated breast cancer patients (examined before and after adjuvant chemotherapy) and 33 BMI-matched two different healthy controls (of 33 healthy controls, 17 BMI-matched control was used to compare before adjuvant chemotherapy, 16 BMI-matched control was used to compare after adjuvant chemotherapy). Age, anthropometric measurements (weight, BMI, waist circumference), and blood biochemistry were recorded. Blood and salivary total ghrelin, obestatin and leptin levels are measured by using ELISA.
Results: The mean ± SD weight (67.2 ± 12.3 and 72.9 ± 11.8 kg., p

Key words: Breast cancer; adjuvant chemotherapy; ghrelin; obestatin, leptin







Bibliomed Article Statistics

23
41
21
18
17
10
13
16
29
33
16
22
R
E
A
D
S

13

21

19

8

13

11

11

11

19

18

20

10
D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.